203. 22q11.2 deletion syndrome Clinical trials / Disease details


Clinical trials : 5 Drugs : 7 - (DrugBank : 1) / Drug target genes : 14 - Drug target pathways : 23

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04639960
(ClinicalTrials.gov)
September 29, 20173/11/2020Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion SyndromeEffects of Modulation of the Dopaminergic System Using Risperidone on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome22q11.2 Deletion SyndromeDrug: Risperdal;Drug: PlaceboUniversity of Geneva, SwitzerlandNULLRecruiting11 Years25 YearsAll30N/ASwitzerland